TINA MATHEWS: Open Payments
NPI 1073768404 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 15 payments from 8 companies in 2025. Trend: 2023 $147 · 2024 $220 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $76 |
| Amgen Inc. | 4 | $73 |
| Indivior Inc. | 3 | $56 |
| Novo Nordisk Inc | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Orexo US, Inc. | 1 | $19 |
| ALK-Abello, Inc | 1 | $18 |
Products named: OTEZLA, SUBLOCADE, TRELEGY ELLIPTA, Rybelsus, LEQVIO, QULIPTA, AREXVY, Zubsolv.
Industry payments across NY — which companies pay providers there.
